Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies?

NCT00295516 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT00295516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies?
Lead sponsor
University of Toronto
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2000
Completion date
August 31, 2004
Enrollment
157
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rh isoimmunization